BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ranjbar S, Seyednejad SA, Nikfar S, Rahimi R, Abdollahi M. How can we develop better antispasmodics for irritable bowel syndrome? Expert Opinion on Drug Discovery 2019;14:549-62. [DOI: 10.1080/17460441.2019.1593369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shulman RJ, Chumpitazi BP, Abdel-Rahman SM, Garg U, Musaad S, Kearns GL. Randomised trial: Peppermint oil (menthol) pharmacokinetics in children and effects on gut motility in children with functional abdominal pain. Br J Clin Pharmacol 2021. [PMID: 34528282 DOI: 10.1111/bcp.15076] [Reference Citation Analysis]
2 Shrivastava A, Mittal A. A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide. Crit Rev Anal Chem 2021;:1-9. [PMID: 34039224 DOI: 10.1080/10408347.2021.1913983] [Reference Citation Analysis]
3 Mousavi T, Nikfar S, Abdollahi M. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opin Drug Metab Toxicol 2020;16:583-604. [PMID: 32380874 DOI: 10.1080/17425255.2020.1767067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]